The key difference is in dosing, as tirzepatide escalation starts at 2.5mg rather than 0.25mg, which means much larger weekly doses and faster vial consumption
We have disclosed this and applied stricter evidence standards as a result, not looser ones
What RUO does mean The compound is supplied for laboratory or investigational research The supplier does not claim medical or therapeutic benefit No dosing, protocols, or administration instructions are provided The product is not marketed to patients In other words: RUO is a research supply model , not a treatment model
It is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2030, reaching USD 230 million by 2030
Building and maintaining a rigorously-vetted catalog backed by our uncompromising standards
In short, B12 injections work, but differently based on your starting point: For those with low levels